drugset / Trial / NCT00423306
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
The study of safety of a new organic arsenic compound in the treatment of advanced hepatocellular carcinoma
Timeline
- Start
- 2007-05-01
- Primary completion
- 2008-08-09
- Completion
- 2008-08-09
Outcome
Outcome not reported
Stopped: “Study closed after Stage 1 (15 of 40 planned patients treated) due to lack of treatment response; criteria to proceed to Stage 2 were not met.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darinaparsin | Small molecule | 420 mg/m2 | — |